Participaciones del usuario Zokatira96

03/02/20 03:26
Ha respondido al tema Farmas USA
  U.S. futures in the green as China plungesFeb. 2, 2020 8:07 PM ET|By: Stephen Alpher, SA News Editor https://seekingalpha.com/news/3537119-u-s-futures-in-green-china-plunges 
Ir a respuesta
31/01/20 12:46
Ha respondido al tema Farmas USA
https://www.bolsamania.com/capitalbolsa/noticias/gurus-de-mercado/la-razon-principal-de-la-caida-del-mercado-de-acciones-no-es-el-coronavirus--7278276.html
Ir a respuesta
31/01/20 01:49
Ha respondido al tema Farmas USA
Pero no os preocupéis,...Luego Superman nos vendrá a ayudar Sera nuestra salvaciónEn Octubre estaremos cerca de 3,300 otra vez NO OLVIDEIS CON VUESTROS VOTO ELECTORAL CON VUESTROS  BIENES AGRADECER  
Ir a respuesta
31/01/20 01:35
Ha respondido al tema Farmas USA
SPY Cuña ascendente en semanal Patrón bajista con stockasticos semanales en DEAD CROSS Chaikiin MF- Acumulacion Distribucion, -y muchos mas y mas se suman a la comparsa.  MACD empezando a girar de EUFORIA A PÁNICO CORONAVIRUS justificacion  o Iran da igual,... tocaba ya   OMS  apoyandoA pocos tendremos el DTrump tweet rematando el empujon todavía mas En abril en 2400/2.700  o mas abajo .,,,..nos vemos Ciao 
Ir a respuesta
28/01/20 00:48
Ha respondido al tema Farmas USA
SPY 500Mensual Shooting Star en formacion -- PPivote S2 EN 3.100RFibo 61% en 2.400
Ir a respuesta
28/01/20 00:30
Ha respondido al tema Farmas USA
Coronavirus ThoughtsJan. 24, 2020 12:35 PM ET|350 comments  | About: iShares MSCI China ETF (MCHI), Includes: SPY, TLTThe current coronavirus outbreak hearkens market participants back to the 2003 outbreak of SARS in China. easiest analogue to the current coronavirus outbreak was the spring 2003 outbreak of Severe Acute Respiratory Syndrome (SARSPrevious experience with SARS, bird flu, and swine flu suggests that a trough in economic activity tends to occur one month to one quarter after the outbreak of the virus.In the 2nd quarter of 2003, the S&P 500 (SPY) soared 12% and long Treasuries (TLT) climbed 5%.Given that tensions between U.S. and China have often dominated market concerns over the past 18 months, a mobilization of U.S. Center for Disease Control personnel to help contain the virus spread in China may be viewed as a potential positive by markets.https://seekingalpha.com/article/4318933-coronavirus-thoughts?utm_source=push&utm_medium=onesignal&utm_campaign=28-1-20-article
Ir a respuesta
26/01/20 17:04
Ha respondido al tema Farmas USA
Futures down more than 1% on Sunday evening https://seekingalpha.com/news/3534544?source=ansh $SPY, $QQQ
Ir a respuesta
24/01/20 02:40
Ha respondido al tema Farmas USA
Agile Therapeutics: 400%+ UpsideJan. 22, 2020 2:51 PM ETSummaryAgile Therapeutics, Inc. is a ~$160 million market capitalization pre-revenue biotech company.The company's lead product, the Twirla contraceptive patch, should be approved by FDA on or before February 16.I expect the share price to rally sharply upon news of this FDA approval.https://seekingalpha.com/article/4318374-agile-therapeutics-400-upside
Ir a respuesta
22/01/20 10:43
Ha respondido al tema Farmas USA
 Vaccine makers tap into virus-driven rally to raise moneyBy Jaimy LeePublished: Jan 22, 2020 10:31 a.m. ET  https://www.marketwatch.com/story/vaccine-makers-tap-into-virus-driven-rally-to-raise-money-2020-01-22?siteid=rss&rss=1 
Ir a respuesta
21/01/20 03:35
Ha respondido al tema Farmas USA
 FDA Decision For Intercept's NASH Drug Ocaliva Delayed; Opportunity Presents Itself  SummaryThe PDUFA date for Ocaliva for the treatment of NASH was pushed up to June 26, 2020, with FDA advisory committee set for April 22, 2020.Efficacy and safety of Ocaliva for treatment of NASH was established in a positive interim update from the phase 3 REGENERATE study.What will be a minor issue might be the safety of the drug, but like Ocaliva's approval for PBC, I predict that FDA may just put a black box label warning.Intercept recently submitted its Marketing Authorization Application for potential approval of Ocaliva for the treatment of NASH in the European Union; opens door for potential sales in another territory.  https://seekingalpha.com/article/4317917-fda-decision-for-intercepts-nash-drug-ocaliva-delayed-opportunity-presents 
Ir a respuesta